Loading viewer...
investor_presentation
Format: PDF investor_presentation
Ocugen's May 2021 corporate deck outlines its mission to develop gene therapies for blindness and a COVID-19 vaccine, highlighting future strategies and market potential.
presentation
investor_presentation
33 Pages
Abacus Life, Inc.
Bowhead Specialty Holdings 2024 Investor Presentation
investor_presentationinvestor_presentation
18 Pages
Bowhead Specialty Holdings
DCM Acquisition RRD Canada Investor Presentation 2023
investor_presentationinvestor_presentation
19 Pages
Data Communications Management Corp.
